ondansetron 4 mg

Ondansetron may have a degree of peripheral selectivity due to binding to P-glycoprotein and efflux out of the brain at the blood–brain barrier. cetirizine 10 mg History A vial of Zofran 4 mg containing ondansetron for intravenous injection Ondansetron (marketed under the brand name Zofran) was developed in the mid-1980s by GlaxoSmithKline in London